VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $24 | -84.1% | 5,471 | -76.1% | 0.00% | -100.0% |
Q2 2023 | $151 | -5.6% | 22,922 | -2.7% | 0.00% | 0.0% |
Q1 2023 | $160 | -14.4% | 23,560 | -7.0% | 0.00% | -50.0% |
Q4 2022 | $187 | -99.9% | 25,342 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $250,000 | -9.1% | 25,342 | +0.5% | 0.00% | -33.3% |
Q2 2022 | $275,000 | -1.4% | 25,216 | +2.1% | 0.00% | +50.0% |
Q1 2022 | $279,000 | -66.1% | 24,696 | -52.8% | 0.00% | -33.3% |
Q4 2021 | $822,000 | +79.9% | 52,342 | +96.2% | 0.00% | -25.0% |
Q3 2021 | $457,000 | -21.6% | 26,680 | -1.6% | 0.00% | -20.0% |
Q2 2021 | $583,000 | +253.3% | 27,102 | +168.8% | 0.01% | +66.7% |
Q4 2019 | $165,000 | -22.9% | 10,084 | +22.9% | 0.00% | -50.0% |
Q4 2018 | $214,000 | – | 8,207 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |